Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Financial incentives for hypertension control: rationale and study design.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215 (Electronic) Linking ISSN: 17456215 NLM ISO Abbreviation: Trials Subsets: MEDLINE
    • Publication Information:
      Original Publication: [London] : BioMed Central, 2006-
    • Subject Terms:
    • Abstract:
      Background: Even though the effectiveness of lifestyle modifications and antihypertensive pharmaceutical treatment for the prevention of hypertension and its complications have been demonstrated in randomized controlled trials, the benefits of adhering to these treatments have not been popularized among the general public. Studies suggest that incentive approaches based on behavioral economic concepts can improve patients' adherence to treatment. Therefore, we aimed to test whether financial incentives will reduce the blood pressure (BP) of hypertensive patients in China.
      Methods/design: This is a multicenter, randomized controlled trial with two parallel arms. A total of 400 participants from six cities in the Liaoning and Shanxi provinces of China are block-randomized into intervention and control group with a 1:1 ratio. Patients in the control group will receive interactive management of mobile devices, including patient education and communication. Patients in the intervention group will receive financial incentives in addition to interactive management of mobile devices, conditional on them achieving their antihypertensive goals or hypertension control. Masking the arm allocation will be precluded by the behavioral nature of the intervention and investigators of BP measurement and statistics are masked to clinic assignment. The primary outcome is net change in systolic BP (SBP) from baseline to month 12 between the intervention and control groups. The secondary outcomes are net change in diastolic BP (DBP), BP control, change in medication adherence and lifestyle, and cost-effectiveness.
      Discussion: This trial will determine whether financial incentives will improve hypertension control and generate necessary data for controlling hypertension and concomitant cardiovascular diseases among hypertensive patients in China.
      Trial Registration: ISRCTN13467677. Registered on 16 May 2019.
    • References:
      JAMA Intern Med. 2018 Jun 1;178(6):802-809. (PMID: 29710289)
      J Hypertens. 2018 Aug;36(8):1637-1647. (PMID: 29847487)
      JAMA Cardiol. 2017 Jul 1;2(7):775-781. (PMID: 28564682)
      JAMA. 2017 Sep 19;318(11):1016-1025. (PMID: 28975305)
      Circulation. 2018 May 29;137(22):2344-2356. (PMID: 29449338)
      JAMA. 2013 Sep 11;310(10):1042-50. (PMID: 24026599)
      JAMA. 2008 Dec 10;300(22):2631-7. (PMID: 19066383)
      JAMA Cardiol. 2017 Jan 1;2(1):67-76. (PMID: 27973671)
      J Exp Psychol Appl. 2001 Sep;7(3):235-50. (PMID: 11676102)
      Am J Med Sci. 2014 Aug;348(2):139-45. (PMID: 24978148)
      Lancet. 2018 Mar 10;391(10124):949-959. (PMID: 29499873)
      Lancet. 2000 Dec 9;356(9246):1955-64. (PMID: 11130523)
      N Engl J Med. 2009 Feb 12;360(7):699-709. (PMID: 19213683)
      JAMA. 2002 Oct 16;288(15):1882-8. (PMID: 12377087)
      Am Heart J. 2005 May;149(5):785-94. (PMID: 15894958)
      J Gen Intern Med. 2014 May;29(5):770-7. (PMID: 24522623)
      JAMA. 2013 Sep 4;310(9):959-68. (PMID: 24002282)
      Circulation. 2016 Feb 9;133(6):592-600. (PMID: 26769742)
      JAMA. 2015 Nov 10;314(18):1926-35. (PMID: 26547464)
      Arch Intern Med. 2008 Nov 24;168(21):2355-61. (PMID: 19029501)
      Hypertension. 2018 Jun;71(6):1269-1324. (PMID: 29133354)
      Value Health. 2008 Jul-Aug;11(4):600-10. (PMID: 18194403)
      Lancet. 2008 May 3;371(9623):1513-8. (PMID: 18456100)
      Lancet. 2010 Jul 17;376(9736):163-72. (PMID: 20619448)
      J Am Coll Cardiol. 2016 Aug 23;68(8):777-85. (PMID: 27539168)
      J Clin Hypertens (Greenwich). 2005 Feb;7(2):102-9. (PMID: 15722655)
      N Engl J Med. 2015 Nov 26;373(22):2103-16. (PMID: 26551272)
    • Grant Information:
      No. 20170541048 Nature Science Foundation of Liaoning Province
    • Contributed Indexing:
      Keywords: Blood pressure control; China; Financial incentives; Hypertension; Randomized controlled trial
    • Accession Number:
      0 (Antihypertensive Agents)
    • Publication Date:
      Date Created: 20200205 Date Completed: 20201124 Latest Revision: 20210110
    • Publication Date:
      20210914
    • Accession Number:
      PMC6998348
    • Accession Number:
      10.1186/s13063-020-4051-7
    • Accession Number:
      32014046